Apremilast

Apremilast | CAS NO: 202409-33-4, Apremilast is primarily used to treat several inflammatory conditions. Psoriasis: It is approved for the treatment of moderate to severe plaque psoriasis in adults. Psoriatic Arthritis: Apremilast is indicated for the treatment of active psoriatic arthritis in adults, either alone or in combination with other therapies. Behçet's Disease: It is also used to manage oral ulcers associated with Behçet's disease. Apremilast works as a phosphodiesterase 4 (PDE4) inhibitor, which helps to reduce inflammation by modulating the immune response. It’s typically taken as an oral medication and may be prescribed when other treatments are not suitable or have not been effective.

We are the Synchemia Research Chemical specializes in manufacturing and supplying of Apremilast impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities and Its Nitrosamine Impurities. Moderate to Severe Plaque Psoriasis: Helps reduce skin lesions and symptoms. Active Psoriatic Arthritis: Treats joint inflammation and pain, improving physical function. Oral Ulcers in Behçet's Disease: Alleviates painful mouth sores associated with this condition. It works by inhibiting phosphodiesterase 4 (PDE4), reducing inflammation and modulating the immune response 4o mini. Buy Reliable and High-Purity Apremilast Impurities, Delivered by Synchemia Research Chemicals.